You are right too!
暂无分享,去创建一个
[1] M. Lopes-Virella,et al. Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation , 1988, The Journal of experimental medicine.
[2] Andrew C. Li,et al. The macrophage foam cell as a target for therapeutic intervention , 2002, Nature Medicine.
[3] Siamon Gordon,et al. Thematic review series: The Immune System and Atherogenesis. Recent insights into the biology of macrophage scavenger receptors Published, JLR Papers in Press, November 16, 2004. DOI 10.1194/jlr.R400011-JLR200 , 2005, Journal of Lipid Research.
[4] J. Little,et al. The role of lipoprotein lipase in the metabolism of triglyceride-rich lipoproteins by macrophages. , 1983, The Journal of biological chemistry.
[5] J. Herz,et al. Lipoprotein receptors in the vascular wall , 2004, Current opinion in lipidology.
[6] S. Hazen,et al. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. , 2000, The Journal of clinical investigation.
[7] A. Tall. Role of ABCA1 in cellular cholesterol efflux and reverse cholesterol transport. , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[8] D. Steinberg,et al. Minimally oxidized low-density lipoprotein increases expression of scavenger receptor A, CD36, and macrosialin in resident mouse peritoneal macrophages. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[9] D. Malide,et al. Macropinocytosis Is the Endocytic Pathway That Mediates Macrophage Foam Cell Formation with Native Low Density Lipoprotein* , 2005, Journal of Biological Chemistry.
[10] J. Borén,et al. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis , 2002, Nature.
[11] E. Miller,et al. Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[12] D. Accili,et al. Increased CD36 protein as a response to defective insulin signaling in macrophages. , 2004, The Journal of clinical investigation.
[13] K. Moore,et al. Scavenger Receptors Class A-I/II and CD36 Are the Principal Receptors Responsible for the Uptake of Modified Low Density Lipoprotein Leading to Lipid Loading in Macrophages* , 2002, The Journal of Biological Chemistry.
[14] J L Witztum,et al. Monoclonal antibodies against LDL further enhance macrophage uptake of LDL aggregates. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.
[15] T. Kodama,et al. Reduced Atherosclerotic Lesions in Mice Deficient for Total or Macrophage-Specific Expression of Scavenger Receptor-A , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[16] G. Getz,et al. Site Specificity of Atherosclerosis: Site-Selective Responses to Atherosclerotic Modulators , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[17] Yukiko Kurihara,et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection , 1997, Nature.
[18] R. Silverstein,et al. Stem Cell Transplantation Reveals That Absence of Macrophage CD36 Is Protective Against Atherosclerosis , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[19] J. Witztum,et al. Minimally Modified LDL Binds to CD14, Induces Macrophage Spreading via TLR4/MD-2, and Inhibits Phagocytosis of Apoptotic Cells* , 2003, The Journal of Biological Chemistry.
[20] Thomas Hartung,et al. CD36 is a sensor of diacylglycerides , 2005, Nature.
[21] K. Moore,et al. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. , 2005, The Journal of clinical investigation.
[22] K. Moore,et al. β-Amyloid promotes accumulation of lipid peroxides by inhibiting CD36-mediated clearance of oxidized lipoproteins , 2004, Journal of Neuroinflammation.
[23] K. Williams,et al. Secretory Sphingomyelinase, a Product of the Acid Sphingomyelinase Gene, Can Hydrolyze Atherogenic Lipoproteins at Neutral pH , 1998, The Journal of Biological Chemistry.
[24] M. Fishbein,et al. Role for Sterol Regulatory Element-Binding Protein in Activation of Endothelial Cells by Phospholipid Oxidation Products , 2004, Circulation research.
[25] T. V. van Berkel,et al. Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerotic lesion development. , 2004, The American journal of pathology.